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It was previously shown that herpes simplex virus type 1 (HSV-1) is sensitive to leptomycin B (LMB), an inhibitor of nuclear export factor
CRM1, and that a single methionine to threonine change at residue 50 (M50T) of viral immediate–early (IE) protein ICP27 can confer LMB
resistance. In this work, we show that deletion of residues 21–63 from ICP27 can also confer LMB resistance. We further show that neither the
M50T mutation nor the presence of LMB affects the nuclear shuttling activity of ICP27, suggesting that another function of ICP27 determines
LMB resistance. A possible clue to this function emerged when it was discovered that LMB treatment of HSV-1-infected cells dramatically
enhances the cytoplasmic accumulation of two other IE proteins, ICP0 and ICP4. This effect is completely dependent on ICP27 and is reversed in
cells infected with LMB-resistant mutants. Moreover, LMB-resistant mutations in ICP27 enhance the nuclear localization of ICP0 and ICP4 even
in the absence of LMB, and this effect can be discerned in transfected cells. Thus, the same amino (N)-terminal region of ICP27 that determines
sensitivity to LMB also enhances ICP27's previously documented ability to promote the cytoplasmic accumulation of ICP4 and ICP0. We
speculate that ICP27's effects on ICP4 and ICP0 may contribute to HSV-1 LMB sensitivity.
© 2006 Elsevier Inc. All rights reserved.Keywords: Herpes simplex virus 1 (HSV-1); ICP27; Leptomycin B; Resistance; Nuclear export; ICP4; ICP0Introduction
During the productive infection of cells by herpes simplex
virus type 1 HSV-1, the viral genes are expressed in a highly
regulated cascade, resulting in the sequential expression of three
viral gene classes: immediate–early (IE), delayed-early (DE),
and late (L) (reviewed in Roizman and Knipe, 2001). Several of
the IE proteins are nuclear proteins that have key roles in
regulating the cascade. One of these, infected cell protein (ICP)
27, is an essential polypeptide that stimulates mRNA and
protein expression from a subset of DE and L genes (McCarthy
et al., 1989; McGregor et al., 1996; Rice and Knipe, 1990;
Sacks et al., 1985; Uprichard and Knipe, 1996). The
mechanisms by which ICP27 selectively activates specific
viral genes are not completely understood, but much evidence
indicates that ICP27 is multifunctional and can stimulate gene
expression via both transcriptional (Jean et al., 2001; McCarthy⁎ Corresponding author. Fax: +1 612 626 0623.
E-mail address: ricex019@umn.edu (S.A. Rice).
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doi:10.1016/j.virol.2006.04.044et al., 1989) and post-transcriptional (Brown et al., 1995; Koffa
et al., 2001; McGregor et al., 1996; Perkins et al., 2003; Sandri-
Goldin, 1998; Sandri-Goldin and Mendoza, 1992; Soliman et
al., 1997) means.
Several recent studies have focused on the role of ICP27 in
viral mRNA export. Because most HSV-1 transcripts are
unspliced, viral mRNAs may not have access to the major
pathway of cellular mRNA transport, in which mRNA export is
coupled to pre-mRNA splicing (Sandri-Goldin, 2004). Rather,
at least some HSV-1 mRNAs appear to require a viral co-factor,
ICP27, for their transport. A similar situation is seen in human
immunodeficiency virus (HIV)-infected cells, wherein the HIV
Rev protein helps mediate the export of unspliced and partially
spliced HIV transcripts (Cullen, 2003). ICP27 has some of the
properties of an mRNA export factor, in that it physically
interacts with RNA (Brown et al., 1995; Mears and Rice, 1996;
Sandri-Goldin, 1998) and shuttles between the nucleus and
cytoplasm (Mears and Rice, 1998; Phelan and Clements, 1997;
Sandri-Goldin, 1998; Soliman et al., 1997). Moreover, several
studies indicate that ICP27 can promote the specific export of
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2001; Sandri-Goldin, 1998; Soliman et al., 1997).
Cells possess multiple transport systems to move RNAs and
proteins from the nucleus to the cytoplasm (reviewed in Lei and
Silver, 2002). These systems utilize soluble transport receptors
that interact directly with the transported cargo, or which
interact indirectly via adaptor proteins. The question of which
cellular export system is utilized by ICP27 has been addressed
in several studies. Most of the recent evidence suggests that
ICP27 utilizes the NXF1 (also called TAP) system, believed to
be the major pathway for bulk export of spliced cellular mRNAs
(reviewed in Dimaano and Ullman, 2004). NXF1 is a non-
karyopherin export receptor that mediates transport of mRNAs
to the cytoplasm, in association with another protein, p15/NXT.
NXF1 can gain access to mRNAs through interaction with the
protein REF (also called Aly), a component of the exon
junctional complex that is deposited upon mRNAs during
splicing. ICP27 physically interacts with REF (Chen et al.,
2002; Koffa et al., 2001) and NXF1 (Chen et al., 2005), thus
providing two potential mechanisms by which ICP27 could be
recruited to the NXF1 pathway. Consistent with this model, the
NXF1 system promotes ICP27-dependent viral mRNA export
in microinjected Xenopus oocytes (Koffa et al., 2001) and
permeabilized infected mammalian cells (Chen et al., 2002).
However, some other evidence suggests that a distinct export
pathway, the CRM1 system (reviewed in Cullen, 2003), could
play a role in ICP27 export. CRM1 is a member of the
karyopherin transport receptor family and is involved in the
export of spliceosomal uridine-rich snRNA and ribosomal
subunits. It is the cellular factor to which Rev binds to promote
HIV mRNA export. CRM1 recognizes its cargo proteins by
binding directly to leucine-rich nuclear export signals (NESs) in
those polypeptides. Several lines of evidence suggest that
CRM1 could play a role in ICP27 export. First, ICP27 has an N-
terminal leucine-rich sequence, mapping to residues 6–19,
which resembles the NES of HIV Rev (Sandri-Goldin, 1998).
This sequence is required for efficient ICP27 nuclear export
(Chen et al., 2005; Lengyel et al., 2002; Sandri-Goldin, 1998)
and can function as an NES when transferred to a heterologous
protein (Sandri-Goldin, 1998). Second, leptomycin B (LMB), a
specific inhibitor of CRM1 export (Yoshida and Horinouchi,
1999), inhibits HSV-1 replication (Murata et al., 2001) and is
reported to prevent the expression of ICP27-responsive viral
genes (Soliman and Silverstein, 2000). Third, it has been
reported that LMB inhibits the cytoplasmic accumulation of
ICP27 (Soliman and Silverstein, 2000), although another study
did not observe this effect (Murata et al., 2001). Fourth, Murata
et al. (2001) isolated an LMB-resistant HSV-1 mutant and
mapped the mutation to a single point mutation in the ICP27
gene, which leads to a methionine to threonine change at residue
50 (M50T). These investigators speculated that the M50T
alteration could enhance the interaction of CRM1 with ICP27,
thus increasing the concentration of LMB needed to disrupt the
interaction and thereby inhibit HSV-1 growth.
As ICP27 is an essential HSV-1 regulatory protein that is
conserved among mammalian and avian herpesviruses (Roiz-
man and Pellett, 2001), it is important to understand its mode ofaction, particularly in regards to viral mRNA export. The
existence of an LMB-resistant ICP27 mutant indicates an
important relationship between ICP27 and CRM1, but it is
unclear if this is due to a direct interaction between the two
proteins during nuclear export. In this study, we have explored
the basis of ICP27-dependent LMB resistance. Our results (i)
further map the N-terminal sequences in ICP27 that are
involved in the LMB resistance phenotype; (ii) suggest that
the resistance mechanism is unlikely to be due to a change in
ICP27's export activity; and (iii) reveal an unexpected linkage
between LMB resistance and the nucleocytoplasmic distribu-
tion of two other HSV-1 IE regulatory proteins, ICP0 and ICP4.
Results
An N-terminal segment of ICP27 is required for LMB
sensitivity
Murata et al. (2001) showed that a single amino acid
alteration in ICP27 (M50T) near the N-terminus can confer
LMB-resistant growth to HSV-1. To explore this finding further,
we engineered the M50T mutation into our laboratory strain of
HSV-1, KOS1.1. Two independent isolates, designated M50T
and M50Tb, were obtained (Fig. 1A). We confirmed the LMB
resistance of both isolates by carrying out plaque assays in Vero
cells at increasing concentrations of LMB (Fig. 1B). As
expected, wild-type (WT) HSV-1 did not efficiently form
plaques at high concentrations of LMB (≥10 ng/ml), whereas
M50T and M50Tb could form plaques in LMB up to a
concentration of 20 ng/ml. In the absence of LMB, the M50T
mutation did not detectably affect HSV-1 plaque size or viral
yields in Vero cells (data not shown).
The formation of a viral plaques is by its nature a low MOI
event. To see if HSV-1 is sensitive to LMB during high MOI
infections, and if resistance can be conferred by an ICP27
mutation under these conditions, we carried out a viral yield
analysis. Vero cells were infected in triplicate with KOS1.1 or
M50T at either high or low MOI (10 or 0.1, respectively), in the
absence or presence of 10 ng/ml LMB, and incubated for one or
two days (for MOI = 10 andMOI = 0.1 infections, respectively).
Viral yields were determined by plaque assay of the infected cell
lysates. The results of the high MOI analysis (Fig. 1C, left)
indicated that WT HSV-1 was significantly inhibited by LMB,
demonstrating a ∼60-fold reduction in viral yield. In contrast,
LMB inhibited M50T by only ∼6-fold. The low MOI infection
showed similar but somewhat more dramatic results (Fig. 1C,
right). We conclude that WT HSV-1 is sensitive to LMB in both
high and low MOI infections, and that the M50T mutation can
confer resistance under both conditions.
Many viral ICP27 mutants, particularly those with lesions in
the carboxyl (C)-terminal half of the gene, are unable to
replicate in non-complementing cells (Lengyel et al., 2002;
McMahan and Schaffer, 1990; Rice and Knipe, 1990; Rice and
Lam, 1994; Rice et al., 1993), and thus it is not possible to ask if
they are LMB resistant. However, we have described several N-
terminal deletion mutants (dAc, d2-3, d3-4, d5-6, and d6-7; Fig.
1A), which replicate comparably to the WT virus in cell culture
Fig. 1. Deletion of an N-terminal region in ICP27 leads to HSV-1 LMB resistance. (A) Summary of the viral ICP27 mutants used in this study. The top bar represents
the 512-residue ICP27 polypeptide. The bars below represent mutant ICP27 polypeptides, with the asterisk indicating the M to T mutation in M50T, and the dotted
lines representing in-frame deletions. (B) LMB resistance of M50T. WT HSV-1, strain KOS1.1, and two independent isolates of M50Twere plaqued on Vero cells in
the absence of LMB (leftmost bars in each series) or in the presence of increasing concentrations of LMB (triangles), and titers were determined. The LMB
concentrations used were 1, 10, and 20 ng/ml. (C) LMB resistance at high or low MOI. Vero cells were infected in triplicate with WTor M50T at an MOI of 10 or 0.1,
in the absence or presence of 10 ng/ml LMB. The high and low MOI infections were incubated for one or two days, respectively. Viral yields were determined by
plaque assay of the infected cell lysates on Vero cells. The bars represent standard deviations. (D) LMB resistance of deletion mutants. Analysis was as in (B), except
that the LMB concentrations used were 2, 5, 10, and 20 ng/ml. Asterisks over the bars indicate that the titer for these samples was less than 2 × 106 PFU/ml.
370 J. Lengyel et al. / Virology 352 (2006) 368–379(Aubert et al., 2001; Lengyel et al., 2002; Mears et al., 1995).
We examined these mutants by plaque assay to see if any
exhibited LMB resistance (Fig. 1D). Although most of the
mutants were LMB sensitive, the mutant dAc, which has a
deletion of residues 21–63, showed LMB resistance similar to
M50T. Interestingly, the sequence deleted in dAc includes
codon 50, the site of the M50T mutation. These results
implicate a specific N-terminal portion of ICP27, corresponding
roughly to residues 21–63, in the leptomycin B resistance
phenotype.
Nuclear export of ICP27 is unaltered by the M50T mutation or
the presence of LMB
Given that LMB inhibits a known nuclear export pathway,
we asked whether the ICP27 polypeptide encoded by an LMB-
resistant mutant exhibits altered export properties. To test this,we compared the nuclear shuttling activity of WT- and M50T-
encoded ICP27 in interspecies heterokaryons (Mears and Rice,
1998). In this assay, HSV-1-infected Vero monkey cells are
fused to uninfected 3T6 mouse cells in the presence of
cycloheximide (CH) to block further protein synthesis. After a
one-hour incubation to allow for protein trafficking, the
localization of ICP27 in interspecies heterokaryons is assessed
by immunofluorescence. The appearance of ICP27 in a mouse
nucleus indicates that the protein has been exported from an
infected monkey nucleus and re-imported. Our previous study
demonstrated that WT ICP27 shuttles very efficiently in this
assay, whereas the ICP27 polypeptide encoded by a C-terminal
ICP27 mutant, M15, is completely unable to shuttle (Mears and
Rice, 1998).
The results of our analysis (Table 1) indicated that the WT
and M50T-encoded ICP27 proteins shuttle with comparable
efficiency, with ≥94% of mouse nuclei in heterokaryons
Table 1
Trafficking of ICP27 within interspecies heterokaryons
Infection No. of heterokaryons
examined




++ a + b
Experiment 1
WT 319 76.8 17.2 6.0
M50T 338 65.7 28.7 5.6
M15 235 0.0 5.5 94.5
WT + LMB 290 69.3 23.8 6.9
M50T + LMB 408 60.3 36.3 3.4
M15 + LMB 177 0.0 1.1 98.9
Experiment 2
WT 226 92.9 3.5 3.5
M50T 218 87.6 10.1 2.3
M15 207 0.0 1.0 99.0
WT + LMB 245 81.2 16.3 2.4
M50T + LMB 214 73.4 24.8 1.9
M15 + LMB 191 0.0 0.5 99.5
a (++) Strong ICP27 staining within 3T6 nuclei (visually comparable in
intensity to that observed in Vero nuclei of same heterokaryon).
b (++) Weak ICP27 staining within 3T6 nuclei (visually less the half the
staining intensity observed in Vero nuclei of same heterokaryon).
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ICP27 was unable to shuttle (E and F), as expected. Moreover,
the addition of 20 ng/ml LMB did not inhibit the export of either
WT- or M50T-encoded ICP27 (Table 1). Although we did not
examine the export of a CRM1-dependent protein to ensure the
efficacy of our LMB, we did demonstrate that LMB treatment of
Vero cells infected in parallel led to a specific and pronounced
effect: the enhanced localization of the IE protein ICP0 in the
cytoplasm (Figs. 2G and H). Below, we demonstrate that this is
a specific and reproducible effect of LMB. Hence, this resultFig. 2. Neither the M50T mutation nor the presence of LMB affects the nuclear shuttl
were infected at an MOI of 10 with WT HSV-1 (A, B,), M50T (C, D), or M15 (E, F).
to prevent further protein synthesis. After 4 h, cell fusion was initiated by the addition
absence or presence of 20 ng/ml LMB. Cells were fixed and ICP27 was identified b
heterokaryons, cells were also stained with Hoechst 33342 to distinguish monkey an
Arrows point to mouse nuclei, which have a characteristic speckled Hoechst-staining
been exported from the infected monkey nucleus. Images from infections without
localization in the heterokaryons. (G, H) Vero cells infected in parallel with those used
ICP0 localization at 9 hpi was assessed by immunofluorescence.demonstrates that the LMB used in the heterokaryon analysis
was biologically active. Therefore, the results of the shuttling
assays allow us to conclude that (i) the M50T mutation does not
qualitatively or quantitatively affect the ability of ICP27 to
shuttle; and (ii) ICP27 does not require CRM1 for its nuclear
export. These findings strongly suggest that LMB resistance
does not result from a change in the nuclear export activity of
ICP27. Rather, we hypothesize that another function or activity
of ICP27 is responsible.
LMB increases the cytoplasmic localization of ICP4 and ICP0
in an ICP27-dependent manner
We next asked whether the M50T mutation or the presence
of LMB affects the steady-state localization of ICP27. To do
this, we fixed infected Vero cells at 6 hpi and processed for
immunofluorescence. The results of this analysis (Fig. 3A, left)
indicated that under all conditions, ICP27 was predominantly
nuclear, with only a low level of cytoplasmic localization. Thus,
neither the M50T mutation nor LMB have a significant affect on
ICP27 localization. This is consistent with our findings above
that neither the M50T mutation nor LMB affect the nuclear
export activity of ICP27.
As a control for the above experiment, we also analyzed
another IE protein, ICP4 (Fig. 3A, right). ICP4 was chosen as a
control because we have previously found that it is not exported
in interspecies heterokaryons (Mears and Rice, 1998), and thus
its localization would not be predicted to be affected by LMB.
Unexpectedly, LMB treatment of WT-infected cells caused a
significant increase in cytoplasmic ICP4 (compare panels e and
f). Intriguingly, this effect was not seen in M50T-infected cells
(panels g and h), raising the possibility that LMB affects the
localization of ICP4 in an ICP27-dependent manner.
Based on the above results, we assessed the effects of LMB
on the localization of HSV IE proteins other than ICP27. ICP4,ing of ICP27. (A–F) ICP27 localization in interspecies heterokaryons. Vero cells
At 4 hpi, uninfected mouse 3T6 cells were added in the presence of 50 μg/ml CH
of PEG and a further one-hour incubation in 100 μg/ml CHwas carried out, in the
y indirect immunofluorescence (red). To aid in the identification of interspecies
d mouse nuclei (blue) and BODIPY-phallacidin to identify stress fibers (green).
pattern. The presence of ICP27 in a mouse nucleus indicates that the protein has
LMB are shown; the presence of LMB had no discernable effect on ICP27
for the heterokaryon analysis were left untreated or treated with 20 ng/ml LMB.
Fig. 3. LMB enhances the cytoplasmic localization of ICP4 and ICP0 in an ICP27-dependent manner. (A–C) Vero cells were mock-infected or infected with the viruses
indicated at an MOI of 10. Cells were fixed at 6 hpi and processed for immunofluorescence with antibodies specific for the viral proteins shown. Where indicated, 20
ng/ml LMB was included in the overlay media.
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the lytic infection (Roizman and Knipe, 2001), were examined.
To do this, we mock-infected or infected Vero cells with WT
HSV-1, M50T, or dAc, then fixed at 6 hpi and processed for
immunofluorescence. In one set of samples, ICP4 localization
was assessed (Fig. 3B, left). As seen before, LMB treatment of
WT-infected cells resulted in significant cytoplasmic accumu-lation of ICP4 compared to untreated cells (panels a and b), and
the M50T mutation largely negated this effect (panels c and d).
Interestingly, the M50T mutation increased ICP4 nuclear
localization relative to WT-infected cells even in the absence
of LMB (compare panels a and c). The results for the dAc
infection (panels e and f) were very similar to those of the M50T
infection, that is, the dAc deletion resulted in the enhanced
373J. Lengyel et al. / Virology 352 (2006) 368–379nuclear localization of ICP4, both in the presence and absence
of LMB. Even more striking results were seen when ICP0 was
examined (Fig. 3B, right). In the WT infection in the absence of
LMB, ICP0 was predominantly nuclear in many cells, although
a fraction of cells showed partial or even predominant
cytoplasmic localization (panel g). The addition of LMB,
however, resulted in a dramatic increase in the fraction of cells
showing cytoplasmic ICP0 and increased the degree to which
ICP0 localized to cytoplasmic granular structures (panel h). In
contrast, ICP0 expressed in both M50T- and dAc-infected cells
was significantly more nuclear compared to WT-infected cells,
both in the presence and absence of LMB (panels i-l). In
contrast to ICP4 and ICP0, ICP22 was not observed to be
affected in its localization by LMB or by the LMB resistance
mutations in ICP27 (data not shown). For all three IE antigens,
mock infections showed minimal to no immunofluorescent
staining (data not shown). We conclude that (i) LMB
significantly enhances the degree to which both ICP4 and
ICP0 localize to the cytoplasm in a WT HSV-1 infection, and
(ii) the M50T and dAc mutations decrease the level of
cytoplasmic ICP4 and ICP0, both in the presence and absence
of LMB.
The above results are reminiscent of studies from Priscilla
Schaffer's laboratory, which showed that ICP27 carries out a
function during HSV-1 infection that acts to enhance the
cytoplasmic localization of ICP4 and ICP0 (Zhu et al., 1994,
1996; Zhu and Schaffer, 1995). To confirm that the effect of
LMB on ICP0 and ICP4 is ICP27-dependent, we examined the
effects of LMB in cells infected with the ICP27 null mutant
d27-1 (Rice and Knipe, 1990). In d27-1-infected cells in the
absence of LMB, ICP4, and ICP0 were both tightly restricted to
the nucleus (Fig. 3C, panels c and g, respectively), consistent
with the work from Schaffer's laboratory. Furthermore, their
localization in d27-1-infected cells was unaffected by LMB
(panels d and h), whereas LMB caused the increased
cytoplasmic localization of ICP4 and ICP0 in WT-infected
cells (panels b and f), as expected. Thus, the effect of LMB on
ICP4 and ICP0 localization is ICP27 dependent.
Time course of ICP4 and ICP0 localization in the presence of
LMB
To gain more insight into how LMB affects ICP0 and ICP4
localization, we carried out time course studies. Vero cells were
infected with WT HSV-1 or M50T, in the absence or presence of
LMB, and stained at 2.5, 5, and 7.5 hpi. In the first experiment,
ICP4 was examined (Fig. 4, top). In WT HSV-1-infected cells,
ICP4 was initially localized nearly exclusively to the nucleus
(panel a). However, it became partially cytoplasmic as infection
progressed (panels b and c). Although LMB did not alter the
initial nuclear localization of ICP4 (panel d), it increased the
extent to which it localized to the cytoplasm at the later time
points (panels e and f). In the M50T infections, in the absence of
the drug, initial localization of ICP4 to the nucleus was
indistinguishable from the WT infection (panel g). At later time
points (panels h and i), however, ICP4 was clearly more
restricted to the nucleus. Moreover, unlike the situation in theWT infection, LMB did not have a dramatic effect on the
localization of ICP4 in the M50T infection (panels j–l).
We next analyzed ICP0 (Fig. 4, bottom). In WT-infected
cells, ICP0 localization was initially nuclear (panel m) but
became progressively more cytoplasmic as the infection
progressed (panels n and o), similar to what has been reported
by others (Elliott et al., 2005; Kawaguchi et al., 1997). At the
earliest time point, LMB had little if any effect on ICP0
localization (panel p), but at the later time points (panels q and
r), it increased the extent of ICP0 cytoplasmic localization and
caused some of it to be located in granular structures. By 7.5
hpi, the majority of ICP0 was cytoplasmic in WT-infected,
LMB-treated cells (panel r). M50T-infected cells were similar to
WT-infected cells at the 2.5-hpi time point, but the pattern at 5
and 7.5 hpi (panels t and u) was substantially different in that
ICP0 did not accumulate as extensively in the cytoplasm.
Moreover, in the M50T infection, LMB did not dramatically
increase the level of cytoplasmic staining compared to untreated
cells and did not cause as much localization in granular
compartments (panels v–x).
Together, the results of the time-course analyses indicate that
LMB does not affect the initial localization of ICP4 and ICP0.
Rather, it inhibits the ability of these proteins to accumulate in
the nucleus at later times in infection. In addition, we conclude
that the M50T mutation increases the extent to which both ICP4
and ICP0 localize to the nucleus in a normal infection in the
absence of drugs.
Alterations in ICP4 and ICP0 localization are not due to
changes in protein abundance
It is possible that some or all of the differences in ICP4 and
ICP0 localization seen in the experiments above could be due to
changes in the abundance of these proteins. To address this
possibility, we carried out an immunoblotting analysis. Vero
cells were infected with WT or M50T in the presence and
absence of LMB, and protein extracts were prepared at 2.5, 5,
and 7.5 hpi. Total proteins from the same number of cell
equivalents were analyzed by immunoblotting (Fig. 5). The
results indicated that neither LMB nor the M50T mutation
significantly altered ICP4 or ICP0 levels at any time point.
Thus, the effects of ICP27 and LMB on nucleocytoplasmic
distribution of ICP4/0 are not due to changes in their abundance.
Furthermore, ICP27 levels (bottom panel) were not greatly
affected by the drug for by the M50T mutation, indicating that
the differences in ICP4 and ICP0 localization are not likely to be
due to changes in the abundance of ICP27.
The M50T mutation promotes ICP4 and ICP0 nuclear
localization in transfected cells
Schaffer and colleagues showed that ICP27 promotes ICP4
and ICP0 cytoplasmic localization even when the proteins are
expressed in transfected cells in the absence of viral infection
(Zhu et al., 1994; Zhu and Schaffer, 1995). Our results indicate
that LMB resistance mutations in ICP27 decrease the level of
cytoplasmic ICP4 and ICP0 in infected cells. To determine
Fig. 4. Time course analysis of ICP4 and ICP0 localization. Vero cells were infected at an MOI of 10 with WT HSV-1 or M50T, in the absence or presence of 20 ng/ml
LMB, and processed for ICP4 or ICP0 immunofluorescence at the times indicated.
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carried out a series of co-transfection experiments. In one set of
experiments, an ICP4-expressing plasmid was transfected into
Vero cells alone, or with a plasmid encoding either WTor M50T
ICP27. After 24 h, the cells were fixed and processed for
immunofluorescence to determine the cellular localization of
the expressed ICP4. The slides bearing the stained samples werecoded and ICP4 localization was assessed in a blinded fashion.
Localization was scored as nuclear (N), nuclear greater than
cytoplasmic (N > C), nuclear comparable to cytoplasmic (N =
C), cytoplasmic greater than nuclear (C > N), and cytoplasmic
(C). Fig. 6A shows representative examples of these localiza-
tion patterns. The combined results of three replicate experi-
ments are shown in Fig. 6B. Consistent with the published
Fig. 5. The levels of ICP4 and ICP0 are unaffected by LMB or by the M50T
mutation. Vero cells were infected with WT HSV-1 or M50Tat an MOI of 10, in
the absence or presence of 10 ng/ml LMB, and total cell proteins were harvested
at the indicated times. Equal cell-equivalents were analyzed for ICP4, ICP0, and
ICP27 levels by immunoblotting.
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predominantly nuclear, and co-expression of WT ICP27
dramatically shifted its distribution to the cytoplasm. Signifi-
cantly, the M50T mutation lessened the extent of this shift,
resulting in higher levels of nuclear ICP4. Similar results were
observed when ICP0 was analyzed by the same method (Fig.
6B), that is, M50T ICP27 was less effective than WT ICP27 inFig. 6. The M50T mutation decreases ICP27's ability to promote the cytoplasmic loc
plasmids encoding ICP4 (A, B) or ICP0 (C, D) with or without a plasmid encoding eit
for immunofluorescence. Localization of ICP4 or ICP0 was assessed in a blinded fa
C > N). Representative staining patterns for ICP4 and ICP0 are shown in panels A
panels B and D, with error bars denoting standard deviations.shifting ICP0 from the nucleus to the cytoplasm. Therefore, we
conclude that the effect of the M50T mutation on the
nucleocytoplasmic distribution of ICP4 and ICP0 does not
require viral infection, nor does it require any other viral
proteins besides ICP27 and ICP4 (in the case of ICP4) or ICP27
and ICP0 (in the case of ICP0). We also attempted to carry out
the plasmid co-transfection analysis in the presence of LMB,
but the combined effects of the transfection protocol and LMB
led to cytotoxic effects that interfered with the analysis.
Discussion
LMB, an unsaturated branched-chain fatty acid isolated from
Streptomyces sp., is a widely used reagent in nuclear export
studies (Yoshida and Horinouchi, 1999). It readily enters cells,
where it binds covalently to the eukaryotic nuclear export factor
CRM1 and prevents it from interacting with its cargo proteins
(Kudo et al., 1998, 1999). Because LMB has no known targets
other than CRM1, we presume that the LMB sensitivity of
HSV-1 reflects a need by the virus to utilize CRM1 during its
lytic infection. Furthermore, as mutations in ICP27 confer LMB
resistance, CRM1 and ICP27 clearly must have an important
relationship. Two general models can be envisioned for this
relationship. First, CRM1 and ICP27 could physically interact,
as would be expected if ICP27 uses CRM1 for its nuclearalization of ICP4 and ICP0 in transfected cells. Vero cells were transfected with
her WT ICP27 or M50T ICP27. One day later, the cells were fixed and processed
shion and scored as nuclear (N), cytoplasmic (C), or mixed (N > C, N = C, or
and C, respectively. The results of three independent experiments are shown in
376 J. Lengyel et al. / Virology 352 (2006) 368–379export. Alternatively, CRM1 and ICP27 might not physically
interact but instead could both participate in a common
biological process.
Two results from our study argue strongly for the second
model, that is, one which involves an indirect interaction
between CRM1 and ICP27. First, we found that the M50T
mutation, which confers LMB resistance, does not qualitatively
or quantitatively alter ICP27's ability to be exported in
interspecies heterokaryons. Second, our assays indicate that
ICP27 can efficiently exit the nucleus in the presence of LMB,
suggesting that CRM1 does not mediate the nuclear export of
ICP27. This latter result is consistent with data from other
investigators who have found that LMB does not inhibit
ICP27's trafficking in other assays of nuclear export (Chen et
al., 2002; Koffa et al., 2001). It is also consistent with emerging
evidence that ICP27 utilizes a distinct pathway, the NXF1
system, for export (Chen et al., 2002, 2005; Koffa et al., 2001).
If LMB-resistant mutations do not alter ICP27's nuclear
export activity, then what ICP27 function do they alter? We can
offer two possible answers, each of which has some potential to
explain the resistance mechanism. The first is that these
mutations determine LMB resistance because they weaken
ICP27's ability to promote the cytoplasmic localization of ICP4
and ICP0. This poorly understood function of ICP27 was
identified several years ago by Schaffer and colleagues (Zhu et
al., 1994; Zhu and Schaffer, 1995). Our study indicates that, for
unknown reasons, LMB enhances this activity, leading to
abnormally high levels of cytoplasmic ICP4 and ICP0 at
intermediate and late stages of infection. LMB resistance
mutations partially reverse this effect, leading to a reduction in
cytoplasmic ICP4 and ICP0. Based on this information, we
suggest that LMB could inhibit WT HSV-1 because it leads to
insufficient levels of ICP4 and/or ICP0 in the nucleus at late
times after infection. Although it is not known if ICP0 has a late
nuclear function, there is evidence that ICP4 is required
continuously throughout infection for the transcription of DE
and L genes (Watson and Clements, 1980), and it is reasonable
to assume that this activity is carried out in the nucleus. It is also
possible that accumulation of abnormally high levels of
cytoplasmic ICP4 and ICP0 may in itself be toxic, and that
this could contribute to LMB sensitivity. In this regard, it is
noteworthy that LMB promotes the accumulation of ICPO in
distinctive granular structures. Similar ICP0-containing struc-
tures have been seen in the cytoplasm of infected cells under
other conditions, including the overexpression of IE proteins
(Knipe and Smith, 1986; Lopez et al., 2001; Zhu et al., 1996),
and may correspond to aggregated ICP0 destined for proteaso-
mal degradation (Lopez et al., 2001).
The hypothesis that LMB sensitivity is due to ICP27-
dependent effects on the localization of ICP4 and ICP0 is
challenged by one recent observation. We have found that the
ICP27 mutant d3-4 (Fig. 1A), which is clearly LMB-sensitive
(Fig. 1D), is similar to M50T and dAc in its decreased ability to
localize ICP4 and ICP0 to the cytoplasm (data not shown).
Thus, the effects of ICP27 on ICP4 and ICP0 do not correlate in
all cases with LMB sensitivity. However, the d3-4 mutant is an
unusual one in regards to the nucleocytoplasmic trafficking ofICP27 in that its encoded ICP27 polypeptide lacks its major
nuclear localization signal (Mears et al., 1995) and is unable to
interact with the REF export factor (Koffa et al., 2001). It is
conceivable that these defects could lead to LMB sensitivity
through a different mechanism.
The second hypothesis for an ICP27 function that is altered
in the LMB-resistant mutants arises from our mapping data. We
found that mutant dAc, which encodes an ICP27 molecule
lacking residues 21–63, displays LMB resistance comparable to
M50T. In contrast, all other ICP27 deletion mutants are fully
sensitive to LMB. Our results thus implicate a specific and non-
essential N-terminal region of ICP27, corresponding roughly to
residues 21–63, in LMB resistance. This is intriguing in light of
recent work by Bachenheimer and colleagues, which indicates
that the very same region of ICP27 is crucial to HSV-1's ability
to activate two distinct mitogen-activated protein kinase
(MAPK) signal transduction pathways: the JNK and p38
pathways (Hargett et al., 2005; McLean and Bachenheimer,
1999). As these two MAPK pathways are activated by cellular
stresses, including ultraviolet light, hypoxia, and inflammation,
JNK and p38 have been termed stress-associated protein kinases
(SAPKs). Although the biological significance of SAPK
activation by ICP27 is unknown, pharmacological agents that
inhibit p38 and JNK lead to small decreases in HSV-1 yields
(Karaca et al., 2004; McLean and Bachenheimer, 1999). This
indicates that the ability of ICP27 to activate SAPK pathways
enhances, but is not essential, for viral replication. Based on the
above information, we hypothesize that the ability of WT ICP27
to activate SAPKs could be responsible for LMB sensitivity.
This could be so, for example, if CRM1 plays a role in
downstream SAPK signaling. In that case, the presence of LMB
might lead to abnormal signaling that could inhibit HSV-1
growth. Consistent with this, at least two downstream
components of the p38 pathway, MK2 and MK5 (also called
MAPKAP2 and PRAK, respectively), are exported from the
nucleus during signaling in a CRM1-dependent fashion (Engel
et al., 1998; Seternes et al., 2002). Moreover, there is evidence
that the shuttling of p38 out of the nucleus following signaling
is CRM1 dependent, likely due to its association with MK2
(Ben-Levy et al., 1998). The M50T and dAc mutations could
confer LMB resistance by decreasing ICP27's ability to activate
SAPKs. CRM1 inhibition in this context would be relatively
inconsequential. Consistent with this model, recent work
indicates that dAc and M50T are defective in activating p38
and JNK (S. Bachenheimer, personal communication). Some-
what surprisingly, these mutants do not appear to exhibit a
replication defect, as might be predicted from the studies with
chemical inhibitors of p38 and JNK (Karaca et al., 2004;
McLean and Bachenheimer, 1999). One possible explanation is
that that other viral factors besides ICP27 might contribute to
SAPK activation during HSV-1 infection. Indeed, recent work
suggests the existence of an ICP27-independent mechanism that
activates p38 at late times after infection (Hargett et al., 2005).
Thus, chemical inhibitors may have more severe effects on
SAPK signaling than do ICP27 mutations.
Irrespective of the phenomenon of LMB resistance, our
study contributes to our basic understanding of ICP27 because
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M50T and dAc display an interesting phenotype even under
normal conditions of infection: they show significantly
increased nuclear localization of ICP4 and ICP0. In this respect,
M50T and dAc represent valuable tools to study ICP27's ability
to promote the cytoplasmic localization of ICP4 and ICP0. At
present, little is known of the biological significance of this
function, or of the mechanism(s) involved. One gap in our
knowledge is that the intracellular trafficking of ICP4 and ICP0
during the HSV-1 infection has not been well defined. Although
both ICP4 and ICP0 localize to the nucleus initially, they begin
to accumulate in the cytoplasm as infection proceeds into the
later phases (Elliott et al., 2005; Kawaguchi et al., 1997; Knipe
et al., 1987; Van Sant et al., 2001; Zhu et al., 1994; Zhu and
Schaffer, 1995). It is not clear whether cytoplasmic accumula-
tion of these proteins is due to their export from the nucleus,
although this has been suggested for ICP0 (Kawaguchi et al.,
1997; Lopez et al., 2001; Van Sant et al., 2001). In the case of
ICP4, it does not appear to be exported from the nucleus, at least
at early times of infection (Mears and Rice, 1998). It is therefore
possible that at least some of the cytoplasmic accumulation of
ICP4, and possibly ICP0, is due to an inhibition of nuclear
import.
Our studies provide new insight into this function of ICP27
by showing that a single amino acid change in ICP27, M50T,
can simultaneously increase the nuclear localization of both
ICP4 and ICP0. Furthermore, in transfected cells, the effect of
the M50T mutation on ICP4 can be discerned in the absence of
ICP0, and conversely the effect on ICP0 can be discerned in the
absence of ICP4 (Fig. 6). These results suggest that the
mechanism by which ICP27 affects the nucleocytoplasmic
distribution of ICP4 and ICP0 does not involve a physical
interaction between ICP27 and these proteins, as it is unlikely
that a single residue could affect both interactions. More likely,
the LMB-resistant mutations affect ICP27's interaction with an
intermediary factor. Given the results of our transfection
experiments, this factor is likely to be cellular.
It is worth noting that the cell-type used for infection can
affect the extent and kinetics of ICP0s appearance in the
cytoplasm (Elliott et al., 2005; Kawaguchi et al., 1997).
Similarly, we have observed that cell-type is important to the
phenomena we describe here, in that neither the M50T mutation
nor LMB appear to affect ICP4 or ICP0 localization in human
diploid fibroblasts, at least at early times after infection (5–7
hpi; data not shown). We have not systematically addressed the
effect of cell type on either HSV-1 LMB resistance or ICP27's
affects on ICP4 and ICP0. Such a study would be interesting,
and might help to elucidate the mechanisms involved.
Finally, our study underscores the multifunctional nature of
ICP27 by showing that certain N-terminal mutations can
specifically affect activities of the protein which are clearly
separate from those required for viral replication. These
functions include the ability to determine LMB resistance, the
modulation of ICP4 and ICP0 localization, and SAPK
activation. Although the biological significance and interrelat-
edness of these activities are presently unclear, it seems likely
that they have evolved to promote the replication, spread, orpersistence of the virus in its natural human host. We expect that
N-terminal ICP27 mutants, including M50T and dAc, will
continue to be important tools in elucidating these enigmatic
functions of ICP27.
Materials and methods
Cells, viruses, and infections
Infections were carried out in Vero (African green monkey
kidney) cells obtained from the American Type Culture
Collection, or in life-extended human foreskin fibroblasts
(Bresnahan et al., 2000), kindly provided by Wade Bresnahan.
Vero cells were propagated in Dulbecco modified Eagle
medium containing 5% heat-inactivated fetal calf serum
(FCS), 50 U/ml penicillin, and 50 μg/ml streptomycin. The
media for the human fibroblasts were the same except that it
contained 10% heat-inactivated FCS. All tissue culture reagents
were purchased from Life Technologies/Invitrogen (Carlsbad,
CA) except FCS, which was purchased from Hyclone (Logan,
UT) or Atlas Biologicals (Fort Collins, CO). Strain KOS1.1
(Hughes and Munyon, 1975) was the WT strain of HSV-1 used
in this study. The ICP27 mutants d27-1 (Rice and Knipe, 1990),
d1-2 (Rice et al., 1993), d2-3 and d6-7 (Aubert et al., 2001), d3-
4 and d4-5 (Mears et al., 1995), d5-6 (Mears and Rice, 1996),
and dLeu and dAc (Lengyel et al., 2002) have all been
described. The derivation of M50T is described below. All
ICP27 mutants except M50T were propagated in V27 cells, a
Vero cell derivative that is stably transfected with the ICP27
gene (Rice and Knipe, 1990). M50T was propagated in Vero
cells.
Infections and plaque assays were carried out as previously
described (Lengyel et al., 2002). Infections for immunofluo-
rescence and immunoblotting were carried out at an MOI of 10.
When used, LMB was added at 1 hpi, as a component of the
overlay medium. LMB was obtained from several sources: as a
generous gift from Minoru Yoshida (RIKEN Institute, Japan) or
purchased from Sigma (St. Louis, MO), Calbiochem (San
Diego, CA), or LC Labs (Woburn, MA). Several side-by-side
comparisons of LMB obtained from different sources indicated
that they all had very similar anti-HSV-1 activity.
Generation of M50T
The codon 50 change, which confers leptomycin B
resistance (M50T), was introduced into the WT ICP27 gene
on plasmid pBS27 (Rice et al., 1993). Mutagenesis was
performed by oligonucleotide-directed mutagenesis using a
commercially available kit (QuikChange Site-directed Muta-
genesis Kit, Stratagene), employing oligonucleotides identical
in sequence to those used by Murata et al. (2001). The resulting
plasmid was designated pBS-LMBR. The mutation was
confirmed by DNA sequencing. For transfer of the mutant
allele into the viral genome, the M50T mutation was introduced
into plasmid pPs27pd1 (Rice et al., 1989), which contains the
ICP27 gene on a 6.0-kb insert. This was done by cloning the
2.4-kb BamHI–SstI fragment of pBS-LMBR into pPs27pd1 in
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altered gene into recombinant HSV-1 genomes, a marker
transfer protocol was used (Rice and Lam, 1994). Mutant
isolates were plaque-purified three times.
Immunofluorescence and immunoblotting
For indirect immunofluorescence, cells were fixed and
permeabilized as described previously (Quinlan et al., 1984).
The antibody used for ICP27 staining was monoclonal antibody
(MAb) H1113, diluted 1:1000. MAb H1114, diluted 1:800, was
used for staining ICP4, and MAb H1112, diluted 1:1000, was
used for staining ICP0. All three antibodies were purchased
from the Rumbaugh-Goodwin Institute for Cancer Research
(Plantation, Florida). Secondary staining was done with Cy3- or
Cy2-conjugated goat anti-mouse IgG (H + L chains), purchased
from Jackson ImmunoResearch Laboratories (West Grove, PA),
diluted 1:1000 or 1:100, respectively. Hoechst dye (0.5 μg/ml)
was included with the secondary antibodies as a nuclear-
specific stain. The cells were examined with an Olympus BX60
fluorescence microscope linked to a video camera. Images were
captured as TIFF files using a CG7 frame grabber (Scion). After
importing the images into Photoshop Elements (Adobe), they
were adjusted for brightness and contrast. Within a given
experiment, all adjustments were done in parallel.
Immunoblotting analysis was performed as described
previously (Perkins et al., 2003), using the monoclonal
antibodies listed above. Immunoreactive proteins were detected
by enhanced chemiluminescence using a commercially avail-
able kit (Amersham).
Interspecies heterokaryon assays
Interspecies heterokaryon assays to determine ICP27 nuclear
export were performed as previously described (Mears and
Rice, 1998), except that polyethylene glycol (PEG) 1500 was
used instead of PEG 8000. Staining of ICP27 and nuclei was
performed as described above; actin stress fibers were stained
with 0.5 U/ml BODIPY FL phallacidin (Molecular Probes).
Analysis of transfected cells
Analysis of the effect of ICP27 on ICP4 or ICP0 localization
in transfected cells was done using the general method
described by Schaffer and colleagues (Zhu et al., 1994; Zhu
and Schaffer, 1995). Briefly, one day prior to transfection, Vero
cells were plated on coverslips in 12-well trays. Transfection of
slightly subconfluent monolayers was carried out the next day
by the calcium phosphate procedure, as previously described
(Rice and Knipe, 1988). Six micrograms of total DNAwas used
per well, consisting of 1 μg of ICP4- or ICP0-encoding plasmid,
and, where applicable, 5 μg of ICP27-encoding plasmid. In
transfections not having an ICP27 plasmid, 5 μg of salmon
sperm DNA was used as carrier. The ICP4-encoding plasmid
used was pK1-2 (DeLuca and Schaffer, 1987); the ICP0-
encoding plasmid was pSHZ (Nabel et al., 1988). The plasmids
used for WT and M50T ICP27 expression were pBS27 andpBS-LMBR, respectively. At 24 h post-transfection, the cells
were fixed, permeabilized, and processed for immunofluores-
cence. Localization patterns in the transfected cells were
assessed in a blinded fashion by coding the samples and having
a second investigator score the localization patterns. For each
combination of plasmids in each experiment, at least 200
positive cells were scored. The data shown in Fig. 6 represent
the means and standard deviations of three separate
experiments.
Acknowledgments
We are grateful to Minoru Yoshida for the gift of LMB and to
Leslie Schiff for many helpful discussions. We also acknowl-
edge Steve Bachenheimer for generously communicating
unpublished results. This research was supported by a grant
from the NIH (R01-AI42737). Anna Strain was supported by a
fellowship from the Minnesota Craniofacial Research Training
(Minncrest) Program (NIH award T32-DE007288).
References
Aubert, M., Rice, S.A., Blaho, J.A., 2001. Accumulation of herpes simplex virus
type 1 early and leaky-late proteins correlates with apoptosis prevention in
infected human HEp-2 cells. J. Virol. 75, 1013–1030.
Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H.F., Marshall, C.J., 1998.
Nuclear export of the stress-activated protein kinase p38 mediated by its
substrate MAPKAP kinase-2. Curr. Biol. 8, 1049–1057.
Bresnahan, W.A., Hultman, G.E., Shenk, T., 2000. Replication of wild-type and
mutant human cytomegalovirus in life-extended human diploid fibroblasts.
J. Virol. 74, 10816–10818.
Brown, C.R., Nakamura, M.S., Mosca, J.D., Hayward, G.S., Straus, S.E.,
Perera, L.P., 1995. Herpes simplex virus trans-regulatory protein ICP27
stabilizes and binds to 3′ ends of labile mRNA. J. Virol. 69, 7187–7195.
Chen, I.H., Sciabica, K.S., Sandri-Goldin, R.M., 2002. ICP27 interacts with the
RNA export factor Aly/REF to direct herpes simplex virus type 1 intronless
mRNAs to the TAP export pathway. J. Virol. 76, 12877–12889.
Chen, I.H., Li, L., Silva, L., Sandri-Goldin, R.M., 2005. ICP27 recruits Aly/REF
but not TAP/NXF1 to herpes simplex virus type 1 transcription sites
although TAP/NXF1 is required for ICP27 export. J. Virol. 79, 3949–3961.
Cullen, B.R., 2003. Nuclear mRNA export: insights from virology. Trends
Biochem. Sci. 28, 419–424.
DeLuca, N.A., Schaffer, P.A., 1987. Activities of herpes simplex virus type 1
(HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15,
4491–4511.
Dimaano, C., Ullman, K.S., 2004. Nucleocytoplasmic transport: integrating
mRNA production and turnover with export through the nuclear pore. Mol.
Cell. Biol. 24, 3069–3076.
Elliott, G., Hafezi, W., Whiteley, A., Bernard, E., 2005. Deletion of the herpes
simplex virus VP22-encoding gene (UL49) alters the expression, localiza-
tion, and virion incorporation of ICP0. J. Virol. 79, 9735–9745.
Engel, K., Kotlyarov, A., Gaestel, M., 1998. Leptomycin B-sensitive nuclear
export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 17,
3363–3371.
Hargett, D., McLean, T., Bachenheimer, S.L., 2005. Herpes simplex virus ICP27
activation of stress kinases JNK and p38. J. Virol. 79, 8348–8360.
Hughes Jr., R.G., Munyon, W.H., 1975. Temperature-sensitive mutants of
herpes simplex virus type 1 defective in lysis but not in transformation.
J. Virol. 16, 275–283.
Jean, S., LeVan, K.M., Song, B., Levine, M., Knipe, D.M., 2001. Herpes
simplex virus 1 icp27 is required for transcription of two viral late (gamma2)
genes in infected cells. Virology 283, 273–284.
Karaca, G., Hargett, D., McLean, T.I., Aguilar, J.S., Ghazal, P., Wagner, E.K.,
Bachenheimer, S.L., 2004. Inhibition of the stress-activated kinase, p38,
379J. Lengyel et al. / Virology 352 (2006) 368–379does not affect the virus transcriptional program of herpes simplex virus type
1. Virology 329, 142–156.
Kawaguchi, Y., Bruni, R., Roizman, B., 1997. Interaction of herpes simplex
virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0
affects translational machinery. J. Virol. 71, 1019–1024.
Knipe, D.M., Smith, J.L., 1986. A mutant herpesvirus protein leads to a block in
nuclear localization of other viral proteins. Mol. Cell. Biol. 6, 2371–2381.
Knipe, D.M., Senechek, D., Rice, S.A., Smith, J.L., 1987. Stages in the nuclear
association of the herpes simplex virus transcriptional activator protein
ICP4. J. Virol. 61, 276–284.
Koffa, M.D., Clements, J.B., Izaurralde, E., Wadd, S., Wilson, S.A., Mattaj,
I.W., Kuersten, S., 2001. Herpes simplex virus ICP27 protein provides
viral mRNAs with access to the cellular mRNA export pathway. EMBO J.
20, 5769–5778.
Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E.P., Yoneda, Y., Yanagida, M.,
Horinouchi, S., Yoshida, M., 1998. Leptomycin B inhibition of signal-
mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242,
540–547.
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E.P., Wolff, B.,
Yoshida, M., Horinouchi, S., 1999. Leptomycin B inactivates CRM1/
exportin 1 by covalent modification at a cysteine residue in the central
conserved region. Proc. Natl. Acad. Sci. U.S.A. 96, 9112–9117.
Lei, E.P., Silver, P.A., 2002. Protein and RNA export from the nucleus. Dev. Cell
2, 261–272.
Lengyel, J., Guy, C., Leong, V., Borge, S., Rice, S.A., 2002. Mapping of
functional regions in the amino-terminal portion of the herpes simplex
virus ICP27 regulatory protein: importance of the leucine-rich nuclear
export signal and RGG box RNA-binding domain. J. Virol. 76,
11866–11879.
Lopez, P., Van Sant, C., Roizman, B., 2001. Requirements for the nuclear-
cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus
1. J. Virol. 75, 3832–3840.
McCarthy, A.M., McMahan, L., Schaffer, P.A., 1989. Herpes simplex virus type
1 ICP27 deletion mutants exhibit altered patterns of transcription and are
DNA deficient. J. Virol. 63, 18–27.
McGregor, F., Phelan, A., Dunlop, J., Clements, J.B., 1996. Regulation of
herpes simplex virus poly (A) site usage and the action of immediate–early
protein IE63 in the early-late switch. J. Virol. 70, 1931–1940.
McLean, T.I., Bachenheimer, S.L., 1999. Activation of cJUN N-terminal kinase
by herpes simplex virus type 1 enhances viral replication. J. Virol. 73,
8415–8426.
McMahan, L., Schaffer, P.A., 1990. The repressing and enhancing functions of
the herpes simplex virus regulatory protein ICP27 map to C-terminal regions
and are required to modulate viral gene expression very early in infection.
J. Virol. 64, 3471–3485.
Mears, W.E., Rice, S.A., 1996. The RGG box motif of the herpes simplex virus
ICP27 protein mediates an RNA-binding activity and determines in vivo
methylation. J. Virol. 70, 7445–7453.
Mears, W.E., Rice, S.A., 1998. The herpes simplex virus immediate–early
protein ICP27 shuttles between nucleus and cytoplasm. Virology 242,
128–137.
Mears, W.E., Lam, V., Rice, S.A., 1995. Identification of nuclear and nucleolar
localization signals in the herpes simplex virus regulatory protein ICP27.
J. Virol. 69, 935–947.
Murata, T., Goshima, F., Koshizuka, T., Takakuwa, H., Nishiyama, Y., 2001. A
single amino acid substitution in the ICP27 protein of herpes simplex virus
type 1 is responsible for its resistance to leptomycin B. J. Virol. 75,
1039–1043.
Nabel, G.J., Rice, S.A., Knipe, D.M., Baltimore, D., 1988. Alternative
mechanisms for activation of human immunodeficiency virus enhancer in
T cells. Science 239, 1299–1302.
Perkins, K.D., Gregonis, J., Borge, S., Rice, S.A., 2003. Transactivation of a
viral target gene by herpes simplex virus ICP27 is posttranscriptional and
does not require the endogenous promoter or polyadenylation site. J. Virol.
77, 9872–9884.
Phelan, A., Clements, J.B., 1997. Herpes simplex virus type 1 immediate early
protein IE63 shuttles between nuclear compartments and the cytoplasm.
J. Gen. Virol. 78, 3327–3331.Quinlan, M.P., Chen, L.B., Knipe, D.M., 1984. The intranuclear location of a
herpes simplex virus DNA-binding protein is determined by the status of
viral DNA replication. Cell 36, 857–868.
Rice, S.A., Knipe, D.M., 1988. Gene-specific transactivation by herpes simplex
virus type 1 alpha protein ICP27. J. Virol. 62, 3814–3823.
Rice, S.A., Knipe, D.M., 1990. Genetic evidence for two distinct transactivation
functions of the herpes simplex virus alpha protein ICP27. J. Virol. 64,
1704–1715.
Rice, S.A., Lam, V., 1994. Amino acid substitution mutations in the herpes
simplex virus ICP27 protein define an essential gene regulation function.
J. Virol. 68, 823–833.
Rice, S.A., Su, L.S., Knipe, D.M., 1989. Herpes simplex virus alpha protein
ICP27 possesses separable positive and negative regulatory activities.
J. Virol. 63, 3399–3407.
Rice, S.A., Lam, V., Knipe, D.M., 1993. The acidic amino-terminal region of
herpes simplex virus type 1 alpha protein ICP27 is required for an essential
lytic function. J. Virol. 67, 1778–1787.
Roizman, B., Knipe, D.M., 2001. Herpes simplex virus and their
replication, In: Knipe, D.M., Howley, P.M. (Eds.), 4th ed. Fields
Virology, vol. 2. Lippincott, Williams and Wilkins, Philadelphia, PA,
pp. 2399–2460.
Roizman, B., Pellett, P.E., 2001. The family Herpesviridae: a brief introduction,
In: Knipe, D.M., Howley, P.M. (Eds.), 4th ed. Fields Virology, vol. 2.
Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 2381–2398.
Sacks, W.R., Greene, C.C., Aschman, D.P., Schaffer, P.A., 1985. Herpes
simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55,
796–805.
Sandri-Goldin, R.M., 1998. ICP27 mediates HSV RNA export by shuttling
through a leucine-rich nuclear export signal and binding viral intronless
RNAs through an RGG motif. Genes Dev. 12, 868–879.
Sandri-Goldin, R.M., 2004. Viral regulation of mRNA export. J. Virol. 78,
4389–4396.
Sandri-Goldin, R.M., Mendoza, G.E., 1992. A herpesvirus regulatory protein
appears to act post-transcriptionally by affecting mRNA processing. Genes
Dev. 6, 848–863.
Seternes, O.M., Johansen, B., Hegge, B., Johannessen, M., Keyse, S.M., Moens,
U., 2002. Both binding and activation of p38 mitogen-activated protein
kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic
distribution of MAPK-activated protein kinase 5 by cellular stress. Mol.
Cell. Biol. 22, 6931–6945.
Soliman, T.M., Silverstein, S.J., 2000. Herpesvirus mRNAs are sorted for
export via Crm1-dependent and -independent pathways. J. Virol. 74,
2814–2825.
Soliman, T.M., Sandri-Goldin, R.M., Silverstein, S.J., 1997. Shuttling of the
herpes simplex virus type 1 regulatory protein ICP27 between the nucleus
and cytoplasm mediates the expression of late proteins. J. Virol. 71,
9188–9197.
Uprichard, S.L., Knipe, D.M., 1996. Herpes simplex ICP27 mutant viruses
exhibit reduced expression of specific DNA replication genes. J. Virol. 70,
1969–1980.
Van Sant, C., Lopez, P., Advani, S.J., Roizman, B., 2001. Role of cyclin D3 in
the biology of herpes simplex virus 1 ICPO. J. Virol. 75, 1888–1898.
Watson, R.J., Clements, J.B., 1980. A herpes simplex virus type 1 function
continuously required for early and late virus RNA synthesis. Nature 285,
329–330.
Yoshida, M., Horinouchi, S., 1999. Trichostatin and leptomycin. Inhibition of
histone deacetylation and signal-dependent nuclear export. Ann. N. Y. Acad.
Sci. 886, 23–36.
Zhu, Z., Schaffer, P.A., 1995. Intracellular localization of the herpes
simplex virus type 1 major transcriptional protein, ICP4, is affected by
ICP27. J. Virol. 69, 49–59.
Zhu, Z., Cai, W., Schaffer, P.A., 1994. Cooperativity among herpes simplex
virus type 1 immediate–early regulatory proteins: ICP4 and ICP27 affect the
intracellular localization of ICP0. J. Virol. 68, 3027–3040.
Zhu, Z., DeLuca, N.A., Schaffer, P.A., 1996. Overexpression of the herpes
simplex virus type 1 immediate–early regulatory protein, ICP27, is
responsible for the aberrant localization of ICP0 and mutant forms of
ICP4 in ICP4 mutant virus-infected cells. J. Virol. 70, 5346–5356.
